Patient Recruitment to Research Studies Hits Three Million - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Patient Recruitment to Research Studies Hits Three Million

Source: Company News Release

More than three million NHS patients in England have taken part in research studies over the last six years supported by the National Institute for Health Research (NIHR) Clinical Research Network.

The Network has today (26 June 2014) published its annual statistics which show that more than 600,000 patients took part in clinical research studies last year alone. During the year the Network hit a recruitment milestone of more than three million patients engaged in clinical research studies in just six years.

Jonathan Sheffield is Chief Executive Officer of the NIHR Clinical Research Network. He said:

“Reaching this milestone is a great achievement. I would like to thank all the patients and carers who have taken part in research, and thereby made a contribution to improving NHS treatments for everyone. We know that research is something that patients really value and to recruit more than three million patients to studies in just six years shows that there is a real appetite from patients to get involved.”

Clinical research is a vital part of the work of the NHS, and a commitment to conduct, promote and use clinical research to improve patient care is part of the NHS England Constitution. Research provides evidence about “what works” so that treatments for patients can be improved. In addition, there is some research evidence to show that patients do better in hospitals and surgeries that do research – even if they don’t actually take part in a study themselves.

Funded by the Department of Health, the NIHR Clinical Research Network is the research delivery arm of the NHS. The Network funds research nurses and health professionals to identify suitable patients and carry out the clinical activities required by the studies. It also provides funds to cover the cost of using scanners, x-rays and other equipment for research purposes. 

Over 99 per cent of NHS Trusts in England now carry out clinical research studies, but Jonathan Sheffield believes there is more to do:

“Our vision is for participation in a clinical research study to be a treatment option for all patients, no matter where they are treated or what condition they have. The Network reconfigured earlier this year to ensure that we are delivering studies across all therapy areas in the NHS throughout England. This will generate valuable opportunities for patients to take part in studies.”

Professor Dame Sally C. Davies FRS FMedSci, Chief Medical Officer and Chief Scientific Adviser at the Department of Health, said:

“The UK life sciences sector is one of the strongest and most productive in the world, in no small part due to our extensive programme to engage the public in research which improves treatments and finds new cures that can make a difference to patients. I am delighted that every hospital in England has now joined in clinical research and hope that this increased access will further grow the UK’s reputation for research excellence.”


ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Company News Release,
Click here